Ken Griffin Kempharm, Inc Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Kempharm, Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 133,500 shares of KMPH stock, worth $659,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,500
Previous 20,000
567.5%
Holding current value
$659,490
Previous $98,000
572.45%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding KMPH
# of Institutions
116Shares Held
26.1MCall Options Held
591KPut Options Held
242K-
Woodline Partners LP San Francisco, CA4.05MShares$20 Million0.18% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.92MShares$14.4 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.76MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY1.7MShares$8.4 Million2.96% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...